{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:59:02Z","timestamp":1791467942396,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP26K10309"],"award-info":[{"award-number":["JP26K10309"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K06634"],"award-info":[{"award-number":["JP22K06634"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neures.2026.105119","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:07:44Z","timestamp":1789085264000},"page":"105119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anti-LAG-3 antibody treatment initiated after symptom onset extends survival in ALS model mice"],"prefix":"10.1016","volume":"231","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4720-967X","authenticated-orcid":false,"given":"Yuta","family":"Morisaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanaka","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1319-4535","authenticated-orcid":false,"given":"Miruto","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoki","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raza","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okiru","family":"Komine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4655-0035","authenticated-orcid":false,"given":"Koji","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemi","family":"Misawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neures.2026.105119_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1291673","article-title":"Depletion of perivascular macrophages delays ALS disease progression by ameliorating blood-spinal cord barrier impairment in SOD1G93A mice","volume":"17","author":"Adachi","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neures.2026.105119_bib2","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.1123511","article-title":"Onset and progression in inherited ALS determined by motor neurons and microglia","volume":"312","author":"Boill\u00e9e","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neures.2026.105119_bib3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3390\/cells14060421","article-title":"Microglia in ALS: insights into mechanisms and therapeutic potential","volume":"14","author":"Bond","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.neures.2026.105119_bib4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.celrep.2013.06.018","article-title":"A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model","volume":"4","author":"Chiu","year":"2013","journal-title":"Cell. Rep."},{"key":"10.1016\/j.neures.2026.105119_bib5","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35097565","article-title":"From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS","volume":"2","author":"Cleveland","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neures.2026.105119_bib6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.celrep.2015.03.053","article-title":"Astrocyte-derived TGF-\u03b21 accelerates disease progression in ALS Mice by interfering with the neuroprotective functions of microglia and T cells","volume":"11","author":"Endo","year":"2015","journal-title":"Cell. Rep."},{"key":"10.1016\/j.neures.2026.105119_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nature17630","article-title":"TAM receptors regulate multiple features of microglial physiology","volume":"532","author":"Fourgeaud","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neures.2026.105119_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2005.02.006","article-title":"Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS","volume":"236","author":"Heiman-Patterson","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neures.2026.105119_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11481-009-9171-5","article-title":"Microglia in ALS: the good, the bad, and the resting","volume":"4","author":"Henkel","year":"2009","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.neures.2026.105119_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","author":"Ilieva","year":"2009","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.neures.2026.105119_bib11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/med.21528","article-title":"Riluzole and edaravone: a tale of two amyotrophic lateral sclerosis drugs","volume":"39","author":"Jaiswal","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neures.2026.105119_bib12","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.neures.2026.105119_bib13","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41586-025-08852-z","article-title":"Immune checkpoint TIM-3 regulates microglia and Alzheimer\u2019s disease","volume":"641","author":"Kimura","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.neures.2026.105119_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/cmi.2011.58","article-title":"C-type lectin receptor-induced NF-\u03baB activation in innate immune and inflammatory responses","volume":"9","author":"Kingeter","year":"2012","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.neures.2026.105119_bib15","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.neures.2026.105119_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.expneurol.2012.06.011","article-title":"Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS","volume":"237","author":"Liao","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neures.2026.105119_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/srep27354","article-title":"Selective expression of osteopontin in ALS-resistant motor neurons is a critical determinant of late phase neurodegeneration mediated by matrix metalloproteinase-9","volume":"6","author":"Morisaki","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neures.2026.105119_bib18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12974-026-03919-8","article-title":"Immune checkpoint LAG-3 governs stage-dependent and disease-associated microglial modules in ALS model mice","volume":"23","author":"Morisaki","year":"2026","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.neures.2026.105119_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1308972","article-title":"LAG-3 expression in microglia regulated by IFN-\u03b3\/STAT1 pathway and metalloproteases","volume":"17","author":"Morisaki","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neures.2026.105119_bib20","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2007.10.034","article-title":"TAM receptors are pleiotropic inhibitors of the innate immune response","volume":"131","author":"Rothlin","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neures.2026.105119_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2202-12-91","article-title":"A comparison of in vitro properties of resting SOD1 transgenic microglia reveals evidence of reduced neuroprotective function","volume":"12","author":"Sargsyan","year":"2011","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neures.2026.105119_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.neures.2026.105119_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/neurosci6030065","article-title":"Meta-analysis of gene expression in bulk-processed post-mortem spinal cord from ALS patients and normal controls","volume":"6","author":"Swindell","year":"2025","journal-title":"NeuroSci"},{"key":"10.1016\/j.neures.2026.105119_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa2109970","article-title":"Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma","volume":"386","author":"Tawbi","year":"2022","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.neures.2026.105119_bib25","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1084\/jem.171.5.1393","article-title":"LAG-3, a novel lymphocyte activation gene closely related to CD4","volume":"171","author":"Triebel","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neures.2026.105119_bib26","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"van Es","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.neures.2026.105119_bib27","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4049\/jimmunol.174.2.688","article-title":"Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223)","volume":"174","author":"Workman","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.neures.2026.105119_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn2047","article-title":"Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis","volume":"11","author":"Yamanaka","year":"2008","journal-title":"Nat. Neurosci."}],"container-title":["Neuroscience Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010226001069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010226001069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:16:47Z","timestamp":1791465407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168010226001069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":28,"alternative-id":["S0168010226001069"],"URL":"https:\/\/doi.org\/10.1016\/j.neures.2026.105119","relation":{},"ISSN":["0168-0102"],"issn-type":[{"value":"0168-0102","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-LAG-3 antibody treatment initiated after symptom onset extends survival in ALS model mice","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neures.2026.105119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105119"}}